The trademark application ADROMAADF was filed by Guangzhou Aogu Biotechnology Co., Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 8, 2024, and still open for oppositions.
The application was filed in English (German was selected as the second language).